MR Imaging Correlates for Molecular and Mutational Analyses in Children with Diffuse Intrinsic Pontine Glioma
暂无分享,去创建一个
R. Beroukhim | K. Ligon | T. Zack | S. Vajapeyam | P. Kao | L. Goumnerova | M. Kieran | K. Wright | D. Brown | C. Jaimes | N. Greenwald | F. Dubois | O. Shapira | N. Gupta | T. Poussaint | S. Chi | C. Jaimes | C. Ma | L. Greenspan | N. Gupta | P. Bandopahayay | C. Ma | Travis Zack | Ofer Shapira | Lianne Greenspan | Douglas L. Brown | N. Gupta | N. Gupta
[1] M. Aboian,et al. Diffusion Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3-K27M Mutation Using Apparent Diffusion Coefficient Histogram Analysis , 2019, American Journal of Neuroradiology.
[2] Ninon Burgos,et al. New advances in the Clinica software platform for clinical neuroimaging studies , 2019 .
[3] Vincent Frouin,et al. Can Structural MRI Radiomics Predict DIPG Histone H3 Mutation and Patient Overall Survival at Diagnosis Time? , 2019, 2019 IEEE EMBS International Conference on Biomedical & Health Informatics (BHI).
[4] Yuanzhong Yang,et al. Noninvasive assessment of H3 K27M mutational status in diffuse midline gliomas by using apparent diffusion coefficient measurements. , 2019, European journal of radiology.
[5] T. MacDonald,et al. Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma , 2018, Neuro-oncology.
[6] Jill S Barnholtz-Sloan,et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015. , 2018, Neuro-oncology.
[7] M. Kool,et al. Magnetic resonance imaging surrogates of molecular subgroups in atypical teratoid/rhabdoid tumor , 2018, Neuro-oncology.
[8] S. Khatua,et al. Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Vincent Frouin,et al. Computation of reliable textural indices from multimodal brain MRI: suggestions based on a study of patients with diffuse intrinsic pontine glioma , 2018, Physics in medicine and biology.
[10] S. Picton,et al. Survival rates and prognostic predictors of high grade brain stem gliomas in childhood: a systematic review and meta-analysis , 2017, Journal of Neuro-Oncology.
[11] S. Vajapeyam,et al. Correlation of 18F-FDG PET and MRI Apparent Diffusion Coefficient Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium , 2017, The Journal of Nuclear Medicine.
[12] M. Aboian,et al. Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation , 2017, American Journal of Neuroradiology.
[13] C. Stevenson,et al. Re-Examining the Need for Tissue Diagnosis in Pediatric Diffuse Intrinsic Pontine Gliomas : A Review , 2016 .
[14] G. Reifenberger,et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.
[15] M. Prados,et al. Biopsy for diffuse intrinsic pontine glioma: a reappraisal. , 2016, Journal of neurosurgery. Pediatrics.
[16] A. Panigrahy,et al. Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium. , 2016, Neuro-oncology.
[17] P. Varlet,et al. Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes , 2015, Acta Neuropathologica.
[18] F. Barkhof,et al. Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria. , 2014, Neuro-oncology.
[19] C. Hawkins,et al. Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications , 2014, Acta Neuropathologica.
[20] K. Yeom,et al. MRI Surrogates for Molecular Subgroups of Medulloblastoma , 2014, American Journal of Neuroradiology.
[21] K. Yeom,et al. Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma , 2014, Journal of Neuro-Oncology.
[22] J. Barnholtz-Sloan,et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.
[23] P. Kearns,et al. Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy – Results of a United Kingdom phase II trial (CNS 2007 04) , 2013, European journal of cancer.
[24] William D. Dunn,et al. MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. , 2013, Radiology.
[25] Johannes E. Schindelin,et al. Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.
[26] David T. W. Jones,et al. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas , 2012, Acta Neuropathologica.
[27] I. Pollack,et al. MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC). , 2011, Neuro-oncology.
[28] W. Reddick,et al. Quantitative Diffusion-Weighted and Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Analysis of T2 Hypointense Lesion Components in Pediatric Diffuse Intrinsic Pontine Glioma , 2011, American Journal of Neuroradiology.
[29] M. Schocke,et al. ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma , 2011, Neuroradiology.
[30] A. Panigrahy,et al. Apparent Diffusion and Fractional Anisotropy of Diffuse Intrinsic Brain Stem Gliomas , 2010, American Journal of Neuroradiology.
[31] R. McLendon,et al. IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.
[32] Frank M. Sacks,et al. IDH 1 and IDH 2 Mutations in Gliomas , 2009 .
[33] Paul S Mischel,et al. Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis. , 2008, Radiology.
[34] M. Prados,et al. Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. , 1996, Pediatric neurosurgery.
[35] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .